Redeye takes a neutral stance to Sdiptech following a much stronger Q2 than we expected. The insignificant impact from the Corona crisis strengthens our view on Sdiptech’s business model, and we argue that the discount to peers should decrease further. We increase our Base case, which, however, remains below the current share price.